The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunomodulation by HDAC inhibition: Results from a phase II study with entinostat and high-dose interleukin 2 in metastatic renal cell carcinoma patients (CTEP#7870).
 
Roberto Pili
Consulting or Advisory Role - Prometheus
Research Funding - Syndax
 
David I. Quinn
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Fresenius Kabi; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Algeta/Bayer; Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
Expert Testimony - Medivation; Teva
 
Hans J. Hammers
Consulting or Advisory Role - Bristol-Myers Squibb; exelixis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Newlink Genetics (Inst); Pfizer (Inst); SFJ Pharmaceuticals Group (Inst); TRACON Pharma (Inst)
 
Paul Monk
No Relationships to Disclose
 
Saby George
Employment - Amgen (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Novartis; Onclive; Pfizer; Xcenda
Research Funding - Acceleron Pharma (Inst); Agensys (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Tanya B. Dorff
Honoraria - Astellas Pharma; Bayer; Medivation; Myriad Genetics; Pfizer; Sanofi
Consulting or Advisory Role - Dendreon; Genentech
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer
Research Funding - Bristol-Myers Squibb
 
Thomas Olencki
No Relationships to Disclose
 
Li Shen
No Relationships to Disclose
 
Dominick M Lamonica
No Relationships to Disclose
 
Alan Hutson
No Relationships to Disclose
 
Adrienne Groman
No Relationships to Disclose
 
Richard Piekarz
No Relationships to Disclose
 
Michael Anthony Carducci
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Clovis Oncology; Medivation; Merck